Cel Sci CVM
NYSE CVM
$1.60 +0.05 (+3.23%)
As of: Oct 21, 2026 · 3:59 PM EDT

Cel Sci (CVM) Short term Debt (2017 - 2018)

Updated

Cel Sci (CVM) recorded Short term Debt of $1.18 million in fiscal Q2 2018 (quarter ended Mar 31, 2018), up 34.5% from the prior quarter.

Analysis

Cel Sci (CVM) Short term Debt (2017 - 2018) Analysis & Trends

At the end of FY2017 (ended Sep 30, 2017), Cel Sci reported Short term Debt of $994,258.

  • Per Business Quant, the preceding three fiscal quarters came in at $874,593 (Q1 2018), $994,258 (Q4 2017) and $325,794 (Q3 2017).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Cel Sci 2.88 Mn -22.77 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2018 1.18 Mn
Dec 31, 2017 874,593.00
Sep 30, 2017 994,258.00
Jun 30, 2017 325,794.00
API Access

Cel Sci Short term Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt&ticker=CVM&period=max&api_key=YOUR_API_KEY